60 day FRN

60471

Federal Register / Vol. 79, No. 194 / Tuesday, October 7, 2014 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60-Day–14–14BAA]

Proposed Data Collections Submitted
for Public Comment and
Recommendations
The Centers for Disease Control and
Prevention (CDC), as part of its
continuing effort to reduce public
burden, invites the general public and
other Federal agencies to take this
opportunity to comment on proposed
and/or continuing information
collections, as required by the
Paperwork Reduction Act of 1995. To
request more information on the below
proposed project or to obtain a copy of
the information collection plan and
instruments, call 404–639–7570 or send
comments to Leroy A. Richardson, 1600
Clifton Road, MS–D74, Atlanta, GA
30333 or send an email to [email protected].
Comments submitted in response to
this notice will be summarized and/or
included in the request for Office of
Management and Budget (OMB)
approval. Comments are invited on: (a)
Whether the proposed collection of
information is necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; (d) ways to
minimize the burden of the collection of
information on respondents, including
through the use of automated collection
techniques or other forms of information
technology; and (e) estimates of capital
or start-up costs and costs of operation,
maintenance, and purchase of services
to provide information. Burden means
the total time, effort, or financial
resources expended by persons to
generate, maintain, retain, disclose or
provide information to or for a Federal
agency. This includes the time needed
to review instructions; to develop,
acquire, install and utilize technology
and systems for the purpose of

collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information, to search
data sources, to complete and review
the collection of information; and to
transmit or otherwise disclose the
information. Written comments should
be received within 60 days of this
notice.

(the ‘‘VP Program’’) to coordinate and
integrate efforts in high-risk
communities involving CDC, national
organizations, and community partners.
Through the VP Program, six national
organizations received cooperative
agreements to assist a total of 18
communities with planning,
implementing, and evaluating
community-based diabetes control
programs. Each VP awardee is required
to use the community change
framework to guide their work with
three communities.
CDC proposes to collect information
to learn more about how the community
change approach is working in
communities that are significantly
impacted by factors that influence the
disproportionate burden of diabetes in
vulnerable populations, such as low
income, limited education, limited
access to health care, and a physical
environment that does not promote
health.
Semi-structured telephone interviews
will be conducted with key personnel
associated with each national
organization (awardee) and each
community site. One project coordinator
and one consultant at each of the six VP
grantee organizations (n=12) will be
asked to participate in an interview of
1.5 hours in length. In addition, an
interview of approximately 1.5 hours
will be conducted with one community
partner or one coalition member at each
community site (n=18) and one site
coordinator at each community site
(n=18) over a two-month period. The
interviews will allow CDC to explore
capacity building and support strategies
used by the awardees to facilitate
community change, and provide insight
into the facilitators and barriers
experienced by the program
stakeholders in addressing diabetes in
their communities.
OMB approval is requested for one
year. Data collection, management, and
analysis will be conducted by a
contractor working on behalf of CDC.
Participation in the interviews is
voluntary and there are no costs to
respondents other than their time.

Proposed Project
A Comprehensive Assessment of the
National Program to Eliminate Diabetes
Related Health Disparities in Vulnerable
Populations—New—National Center for
Chronic Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
Diabetes affects over 29 million
people in the United States, is the sixth
leading cause of death in the country,
and can cause serious health
complications including heart disease,
blindness, kidney failure, and lowerextremity amputations. The overall
prevalence of diabetes in the U.S. is >
9%, however, higher rates of type 2
diabetes and its complications exist in
particular subgroups of the population.
These subgroups include adults ages 60
years and older, racial and ethnic
minority groups (e.g., African
Americans, Hispanic/Latino Americans,
American Indians, Native Hawaiians
and other Pacific Islanders, and some
Asian Americans), people with low
socioeconomic status (SES), and rural
populations. Population subgroups that
are not well integrated into the health
care system because of ethnic, cultural,
economic, or geographic characteristics,
and that may not receive adequate
health care, are considered vulnerable
populations.
In an effort to reduce diabetes-related
disparities, CDC’s Division of Diabetes
Translation (DDT) aims to concentrate
efforts where the greatest impact can be
achieved for populations with the
greatest burden or risk of diabetes. DDT
established the National Program to
Eliminate Diabetes Related Health
Disparities in Vulnerable Populations

asabaliauskas on DSK5VPTVN1PROD with NOTICES

ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents

Number of
responses per
respondent

Average
burden per
response
(in hours)

Total
burden
hours

Type of respondent

Form name

Grantee (Staff Designee and Consultant).
Community Partner/Coalition Member.

Grantee Interview Guide ..................

12

1

1.5

18

Community Partner/Coalition Member Interview Guide.

18

1

1.5

27

VerDate Sep<11>2014

17:15 Oct 06, 2014

Jkt 235001

PO 00000

Frm 00028

Fmt 4703

Sfmt 4703

E:\FR\FM\07OCN1.SGM

07OCN1

60472

Federal Register / Vol. 79, No. 194 / Tuesday, October 7, 2014 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Average
burden per
response
(in hours)

Total
burden
hours

Form name

Site Coordinator ................................

Site Coordinator Interview Guide .....

18

1

1.5

27

Total ...........................................

...........................................................

........................

........................

........................

72

Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

Centers for Disease Control and
Prevention

Centers for Disease Control and
Prevention

[FR Doc. 2014–23865 Filed 10–6–14; 8:45 am]

Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review

Advisory Board on Radiation and
Worker Health (ABRWH or Advisory
Board), National Institute for
Occupational Safety and Health
(NIOSH)

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

The meeting announced below
concerns Workers’ Compensation
Surveillance, PAR14–227, initial
review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:

Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel: Notice of Charter
Renewal

asabaliauskas on DSK5VPTVN1PROD with NOTICES

Number of
responses per
respondent

Number of
respondents

Type of respondent

This gives notice under the Federal
Advisory Committee Act (Pub. L. 92–
463) of October 6, 1972, that the charter
for the Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel, Centers for Disease
Control and Prevention, Department of
Health and Human Services, has been
renewed for a 2-year period through
September 18, 2016.
For information, contact Catherine
Ramadei, Acting Designated Federal
Officer, Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel, Centers for Disease
Control and Prevention, Department of
Health and Human Services, 1600
Clifton Road NE., Mailstop K48, Atlanta,
Georgia 30333, telephone (770) 488–
4796 or fax (404) 248–4152.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.

Time and Date: 11:00 a.m.–7:00 p.m.,
November 5, 2014 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c) (4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters for Discussion: The meeting will
include the initial review, discussion, and
evaluation of applications received in
response to ‘‘Workers’ Compensation
Surveillance, PAR14–227, initial review.’’
Contact Person for More Information:
Donald Blackman, Ph.D., Scientific Review
Officer, CDC, 2400 Century Center Parkway
NE., 4th Floor, Room 4204, Mailstop E–74,
Atlanta, Georgia 30345, Telephone: (404)
498–6185, [email protected] .
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2014–23854 Filed 10–6–14; 8:45 am]
BILLING CODE 4163–18–P

[FR Doc. 2014–23858 Filed 10–6–14; 8:45 am]
BILLING CODE 4163–18–P

VerDate Sep<11>2014

17:15 Oct 06, 2014

Jkt 235001

PO 00000

Frm 00029

Fmt 4703

Sfmt 4703

In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:
Time and Date: 8:15 a.m.–4:30 p.m.,
Pacific Daylight Time, November 6,
2014.
Public Comment Time and Date: 4:30
p.m.–5:30 p.m., Pacific Daylight Time,
November 6, 2014.
Place: Hilton Garden Inn Los Angeles/
Redondo Beach, 2410 Marine Avenue,
Redondo Beach, CA 90278, Phone: 310–
727–9999; Fax: 310–727–9998. Audio
Conference Call via FTS Conferencing.
The USA toll-free, dial-in number is 1–
866–659–0537 with a pass code of
9933701.
Live Meeting Connection: https://
www.livemeeting.com/cc/cdc/join?id=
ZN5GQZ&role=attend&pw=ABRWH;
Meeting ID: ZN5GQZ; Entry Code:
ABRWH.
Status: Open to the public, limited
only by the space available. The meeting
space accommodates approximately 100
people.
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation
Program Act of 2000 to advise the
President on a variety of policy and
technical functions required to
implement and effectively manage the
new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines
which have been promulgated by the
Department of Health and Human
Services (HHS) as a final rule, advice on
methods of dose reconstruction which
have also been promulgated by HHS as
a final rule, advice on the scientific

E:\FR\FM\07OCN1.SGM

07OCN1